Loading
Disease Outbreaks / Sequence Analysis, DNA / Antibodies, Bacterial · Journal article
Diagnostic Microbiology and Infectious Disease · August 4, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is an outbreak-based molecular diagnostics study reporting detection of O. tsutsugamushi DNA in serum using nested PCR targeting the 47-kDa htrA gene and phylogenetic analysis of a single tsa56 amplicon. The work validates a PCR assay in an endemic setting and identifies strain diversity, but lacks clinical outcome data, formal diagnostic accuracy metrics, and replication of genotyping findings.
Outbreak investigation with molecular diagnostics and phylogenetic analysis. Individuals with serum samples available from a scrub typhus outbreak in Vellore and adjacent districts, Tamil Nadu, India; stratified by IgM ELISA status.. Intervention: Nested PCR targeting 47-kDa htrA gene; tsa56 gene amplification and sequencing in one positive sample. Compared with: IgM ELISA serology. n = 40. Vellore and adjacent districts, Tamil Nadu, India.
Nested PCR detected O. tsutsugamushi DNA in all 9 IgM ELISA-positive samples and in 10 of 31 IgM-negative samples (19/40 total positive) tsa56 gene amplified from only 1 serum sample (1571 bp) Phylogenetic analysis revealed three distinct clusters; study isolate closely related to Cluster A
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
This work supports the integration of nested PCR targeting htrA with serological testing to improve early diagnosis of scrub typhus in endemic regions. However, the single tsa56 sequence limits conclusions about strain diversity and vaccine targets; clinicians should note that molecular surveillance remains underdeveloped in this geography.
Diagnostic validation study in an outbreak setting with modest sample size and primarily descriptive molecular findings; detects pathogen DNA but lacks clinical outcome data or comparative diagnostic accuracy metrics.
As stated by the source record.
Quoted from the source exactly as published.
This work supports the integration of nested PCR targeting htrA with serological testing to improve early diagnosis of scrub typhus in endemic regions. However, the single tsa56 sequence limits conclusions about strain diversity and vaccine targets; clinicians should note that molecular surveillance remains underdeveloped in this geography.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Scrub typhus, caused by Orientia tsutsugamushi, is a clinically important vector-borne disease in the Asia-Pacific region. This study aimed to detect O. tsutsugamushi DNA in human serum samples collected during a scrub typhus outbreak in Vellore and adjacent districts of Tamil Nadu, India, and to genotype the pathogen based on the tsa56 gene sequence. A total of 40 serum samples were analyzed, including nine IgM ELISA-positive samples and 31 IgM-negative samples. Nested PCR targeting the 47-kDa htrA gene detected O. tsutsugamushi DNA in all nine IgM-positive samples and in 10 of the 31 IgM-negative samples, confirming the presence of O. tsutsugamushi DNA in serum. This study demonstrates the detection of Orientia tsutsugamushi DNA in human serum using a 47-kDa htrA gene-based nested PCR assay and highlights the value of integrating this molecular approach with IgM ELISA for early and accurate diagnosis of scrub typhus. From one serum sample, the 1571-bp tsa56 gene was amplified. The tsa56 gene based phylogenetic analysis revealed three distinct clusters within this geography and the isolate from this study was closely related to Cluster A. Amino acid sequence alignment of the TSA56 variable domains indicated distinct variations in VD-I, II and III, while VD-IV remained conserved in Clusters B and C. These findings highlight the importance of integrating molecular diagnostics with serology and emphasize the need for improved molecular surveillance and diagnostics to better characterize strain diversity, improve disease management and vaccine development.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.